| Intestinal permeation enhancers for oral peptide delivery S Maher, RJ Mrsny, DJ Brayden Advanced drug delivery reviews 106, 277-319, 2016 | 326 | 2016 |
| Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro S Maher, S McClean Biochemical pharmacology 71 (9), 1289-1298, 2006 | 301 | 2006 |
| Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic S Maher, TW Leonard, J Jacobsen, DJ Brayden Advanced drug delivery reviews 61 (15), 1427-1449, 2009 | 265 | 2009 |
| Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C10) C Twarog, S Fattah, J Heade, S Maher, E Fattal, DJ Brayden Pharmaceutics 11 (2), 78, 2019 | 176 | 2019 |
| Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches DJ Brayden, TA Hill, DP Fairlie, S Maher, RJ Mrsny Advanced drug delivery reviews 157, 2-36, 2020 | 172 | 2020 |
| Application of permeation enhancers in oral delivery of macromolecules: an update S Maher, DJ Brayden, L Casettari, L Illum Pharmaceutics 11 (1), 41, 2019 | 135 | 2019 |
| Overcoming poor permeability: translating permeation enhancers for oral peptide delivery S Maher, DJ Brayden Drug Discovery Today: Technologies 9 (2), e113-e119, 2012 | 111 | 2012 |
| A Whey Protein Hydrolysate Promotes Insulinotropic Activity in a Clonal Pancreatic β-Cell Line and Enhances Glycemic Function in ob/ob Mice1–3 C Gaudel, AB Nongonierma, S Maher, S Flynn, M Krause, BA Murray, ... The Journal of nutrition 143 (7), 1109-1114, 2013 | 95 | 2013 |
| Oral delivery of macromolecules: rationale underpinning Gastrointestinal Permeation Enhancement Technology (GIPET®) EG Walsh, BE Adamczyk, KB Chalasani, S Maher, EB O’Toole, JS Fox, ... Therapeutic delivery 2 (12), 1595-1610, 2011 | 89 | 2011 |
| Melittin exhibits necrotic cytotoxicity in gastrointestinal cells which is attenuated by cholesterol S Maher, S McClean Biochemical pharmacology 75 (5), 1104-1114, 2008 | 89 | 2008 |
| Formulation strategies to improve oral peptide delivery S Maher, B Ryan, A Duffy, DJ Brayden Pharmaceutical patent analyst 3 (3), 313-336, 2014 | 68 | 2014 |
| Restoration of rat colonic epithelium after in situ intestinal instillation of the absorption promoter, sodium caprate X Wang, S Maher, DJ Brayden Therapeutic delivery 1 (1), 75-82, 2010 | 57 | 2010 |
| Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae S Maher, R Kennelly, VA Bzik, AW Baird, X Wang, D Winter, DJ Brayden European journal of pharmaceutical sciences 38 (4), 291-300, 2009 | 57 | 2009 |
| Cracking the junction: update on the progress of gastrointestinal absorption enhancement in the delivery of poorly absorbed drugs S Maher, DJ Brayden, L Feighery, S McClean Critical Reviews™ in Therapeutic Drug Carrier Systems 25 (2), 2008 | 55 | 2008 |
| Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers SB Petersen, G Nolan, S Maher, UL Rahbek, M Guldbrandt, DJ Brayden European journal of pharmaceutical sciences 47 (4), 701-712, 2012 | 54 | 2012 |
| Intestinal permeation enhancers to improve oral bioavailability of macromolecules: Reasons for low efficacy in humans S Maher, C Geoghegan, DJ Brayden Expert opinion on drug delivery 18 (2), 273-300, 2021 | 47 | 2021 |
| The mycotoxin patulin increases colonic epithelial permeability in vitro HM Mohan, D Collins, S Maher, EG Walsh, DC Winter, PJ O’Brien, ... Food and chemical toxicology 50 (11), 4097-4102, 2012 | 47 | 2012 |
| Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers S Maher, L Feighery, DJ Brayden, S McClean Pharmaceutical research 24, 1336-1345, 2007 | 47 | 2007 |
| Chitooligosaccharide elicits acute inflammatory cytokine response through AP-1 pathway in human intestinal epithelial-like (Caco-2) cells B Bahar, JV O’Doherty, S Maher, J McMorrow, T Sweeney Molecular immunology 51 (3-4), 283-291, 2012 | 46 | 2012 |
| Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies S Maher, X Wang, V Bzik, S McClean, DJ Brayden European journal of pharmaceutical sciences 38 (4), 301-311, 2009 | 45 | 2009 |
